Loading organizations...
§ Private Profile · Fremont, CA, USA
Manufactures spectral flow cytometry instruments, reagents, and solutions for biomedical research and clinical applications.
Founded by Wenbin Jiang, Ming Yan, and Eric Chase, Cytek Biosciences is a Fremont, California-based company that manufactures flow cytometry products and reagents for biomedical research and clinical applications. The organization develops spectral flow cytometry solutions utilizing its patented Full Spectrum Profiling technology to simplify cell analysis workflows, reduce operational costs, and accelerate scientific discoveries. First established in 1992 as Cytek Development, the enterprise officially adopted its current corporate identity following a strategic merger in August 2015. To support ongoing commercial expansion and scale its global installed base of laboratory instruments, the business successfully secured approximately $12 million in Series B venture financing in 2016. Today, Chief Executive Officer Wenbin Jiang and Chief Technology Officer Ming Yan continue to lead the firm in providing specialized cell analysis tools to researchers across the broader biomedical sector.
Cytek Biosciences has raised $120.0M across 1 funding round.
Cytek Biosciences has raised $120.0M in total across 1 funding round.
Cytek Biosciences has raised $120.0M in total across 1 funding round.
Cytek Biosciences's investors include Hillhouse Capital, Andrew Levin, LYFE Capital, OrbiMed.
Cytek Biosciences has raised $120.0M across 1 funding round. Most recently, it raised $120.0M Series D in November 2020.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Nov 5, 2020 | $120M Series D | Hillhouse Capital, Andrew Levin | Lyfe Capital, OrbiMed | Announced |